Balance Sheet - Krystal Biotech, Inc. (KRYS)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 827.79 | 597.52 | 532.18 | 379.17 | 438.10 | 271.26 | 193.69 | 111.76 | 49.59 | 1.92 |
| Accounts receivable, net | 127.43 | 104.75 | 42.04 | 0.00 | ||||||
| Inventories | 40.48 | 26.51 | 6.99 | 0.00 | 0.00 | |||||
| Other current assets | 28.91 | 13.27 | 6.71 | 4.61 | 4.17 | 3.80 | 2.20 | 0.89 | 0.32 | 0.25 |
| Total current assets | 1,024.60 | 742.05 | 587.91 | 383.78 | 442.27 | 275.06 | 195.88 | 112.65 | 49.91 | 2.17 |
| Total non-current assets | 309.19 | 313.79 | 230.45 | 174.67 | 184.03 | 35.79 | 13.14 | 3.47 | 0.20 | 0.01 |
| Total assets | 1,333.79 | 1,055.84 | 818.36 | 558.45 | 626.30 | 310.84 | 209.02 | 116.12 | 50.11 | 2.18 |
| Total current liabilities | 102.94 | 102.00 | 33.09 | 28.85 | 25.74 | 15.45 | 3.33 | 2.60 | 0.64 | 0.04 |
| Total non-current liabilities | 11.29 | 7.46 | 6.62 | 7.37 | 6.98 | 3.31 | 2.78 | 0.29 | 0.00 | 1.85 |
| Total liabilities | 114.23 | 109.46 | 39.71 | 36.22 | 32.72 | 18.76 | 6.11 | 2.89 | 0.64 | 1.89 |
| Total stockholders' equity | 1,219.56 | 946.38 | 778.64 | 522.23 | 593.58 | 292.08 | 202.91 | 113.23 | 49.47 | 0.29 |
| Common shares outstanding | 30 | 30 | 28 | 25 | 22 | 19 | 16 | 11 | 5 | 4 |
Show Quarterly Balance Sheet
Balance Sheet - Krystal Biotech, Inc. (KRYS)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | Dec-19 | Sep-19 | Jun-19 | Mar-19 | Dec-18 | Sep-18 | Jun-18 | Mar-18 | Dec-17 | Sep-17 | Jun-17 | Mar-17 | Dec-16 | Sep-16 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 823.41 | 827.79 | 731.07 | 681.99 | 616.85 | 597.52 | 588.32 | 559.61 | 538.26 | 532.18 | 562.07 | 477.52 | 350.39 | 379.17 | 394.42 | 425.57 | 434.63 | 438.10 | 343.09 | 367.73 | 403.42 | 271.26 | 286.37 | 297.17 | 186.70 | 193.69 | 203.21 | 195.47 | 106.63 | 111.76 | 52.29 | 45.45 | 47.23 | 49.59 | 52.57 | 3.52 | 1.96 | 1.92 | 0.00 |
| Accounts receivable, net | 127.02 | 127.43 | 129.63 | 111.44 | 103.26 | 104.75 | 97.30 | 103.24 | 46.47 | 42.04 | 9.32 | 0.00 | |||||||||||||||||||||||||||
| Inventories | 42.65 | 40.48 | 37.63 | 31.04 | 29.94 | 26.51 | 18.58 | 12.18 | 11.04 | 6.99 | 5.28 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||||||||||
| Other current assets | 26.67 | 28.91 | 27.32 | 16.88 | 16.75 | 13.27 | 8.96 | 7.75 | 6.49 | 6.71 | 5.47 | 6.49 | 5.04 | 4.61 | 3.16 | 3.21 | 3.37 | 4.17 | 2.72 | 2.20 | 2.41 | 3.80 | 1.29 | 1.37 | 1.63 | 2.20 | 2.45 | 1.47 | 2.53 | 0.89 | 1.05 | 0.52 | 0.88 | 0.32 | 0.05 | 0.12 | 0.17 | 0.25 | |
| Total current assets | 1,019.74 | 1,024.60 | 925.65 | 841.35 | 766.80 | 742.05 | 713.16 | 682.77 | 602.25 | 587.91 | 582.13 | 484.00 | 355.43 | 383.78 | 397.58 | 428.77 | 438.00 | 442.27 | 345.81 | 369.93 | 405.83 | 275.06 | 287.65 | 298.54 | 188.33 | 195.88 | 204.44 | 196.20 | 107.89 | 112.65 | 52.82 | 45.71 | 47.67 | 49.91 | 52.62 | 3.93 | 2.13 | 2.17 | |
| Total non-current assets | 377.23 | 309.19 | 314.44 | 297.05 | 307.62 | 313.79 | 269.15 | 234.89 | 251.05 | 230.45 | 208.22 | 200.02 | 176.42 | 174.67 | 178.80 | 172.55 | 178.88 | 184.03 | 105.28 | 73.63 | 37.19 | 35.79 | 23.80 | 19.61 | 16.80 | 13.14 | 9.80 | 8.95 | 7.81 | 3.47 | 1.63 | 0.32 | 0.18 | 0.20 | 0.06 | 0.05 | 0.02 | 0.01 | |
| Total assets | 1,396.97 | 1,333.79 | 1,240.09 | 1,138.39 | 1,074.42 | 1,055.84 | 982.32 | 917.66 | 853.30 | 818.36 | 790.35 | 684.03 | 531.85 | 558.45 | 576.38 | 601.32 | 616.87 | 626.30 | 451.10 | 443.56 | 443.02 | 310.84 | 311.45 | 318.15 | 205.13 | 209.02 | 214.23 | 205.16 | 115.70 | 116.12 | 54.45 | 46.03 | 47.85 | 50.11 | 52.67 | 3.98 | 2.15 | 2.18 | |
| Total current liabilities | 107.80 | 102.94 | 91.27 | 86.90 | 79.49 | 102.00 | 89.53 | 71.85 | 47.59 | 33.09 | 27.58 | 23.90 | 35.08 | 28.85 | 28.03 | 34.43 | 60.44 | 25.74 | 35.78 | 18.12 | 9.14 | 15.45 | 7.20 | 5.83 | 4.06 | 3.33 | 3.73 | 3.94 | 3.24 | 2.60 | 1.92 | 0.76 | 0.45 | 0.64 | 2.48 | 0.58 | 0.09 | 0.04 | |
| Total non-current liabilities | 12.44 | 11.29 | 10.95 | 10.85 | 10.25 | 7.46 | 6.95 | 6.91 | 6.47 | 6.62 | 6.82 | 7.01 | 7.21 | 7.37 | 7.58 | 7.72 | 7.88 | 6.98 | 7.08 | 6.90 | 3.22 | 3.31 | 2.53 | 2.62 | 2.70 | 2.78 | 2.86 | 2.93 | 2.98 | 0.29 | 0.25 | 2.18 | 1.85 | ||||||
| Total liabilities | 120.24 | 114.23 | 102.22 | 97.75 | 89.74 | 109.46 | 96.47 | 78.77 | 54.05 | 39.71 | 34.40 | 30.91 | 42.28 | 36.22 | 35.61 | 42.14 | 68.32 | 32.72 | 42.86 | 25.02 | 12.37 | 18.76 | 9.73 | 8.45 | 6.76 | 6.11 | 6.59 | 6.87 | 6.22 | 2.89 | 2.16 | 0.76 | 0.45 | 0.64 | 2.48 | 0.58 | 2.27 | 1.89 | |
| Total stockholders' equity | 1,276.73 | 1,219.56 | 1,137.88 | 1,040.65 | 984.67 | 946.38 | 885.85 | 838.89 | 799.24 | 778.64 | 755.95 | 653.11 | 489.57 | 522.23 | 540.77 | 559.18 | 548.55 | 593.58 | 408.24 | 418.54 | 430.65 | 292.08 | 301.72 | 309.70 | 198.37 | 202.91 | 207.65 | 198.29 | 109.49 | 113.23 | 52.29 | 45.27 | 47.40 | 49.47 | 50.20 | 3.39 | -0.11 | 0.29 | |
| Common shares outstanding | 31 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 29 | 29 | 29 | 27 | 26 | 26 | 26 | 26 | 25 | 22 | 22 | 22 | 21 | 20 | 20 | 18 | 17 | 17 | 17 | 15 | 14 | 14 | 11 | 10 | 10 | 10 | 4 | 9 | 4 | 4 | 4 |